Bay Area's Arcus Biosciences Scores $107M, Initiates Two Clinical Trials Post author:Sam Post published:November 12, 2017 Post category:BioPharma Now totaling $227M, Arcus Biosciences announced it had closed a $107M Series C financing. Source: BioSpace You Might Also Like Cryogenic Logistics Company CryoPort Grabs Contracts for Gilead, Novartis CAR-T Products November 2, 2017 Inovio Pharma To Report First Quarter 2017 Financial Results May 10, 2017 April 25, 2017 6 Promising Biopharmas With Major Catalysts in 2018 January 28, 2018
Cryogenic Logistics Company CryoPort Grabs Contracts for Gilead, Novartis CAR-T Products November 2, 2017